Herantis Pharma Oyj
HEL:HRTIS.HE
1.69 (EUR) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 0.28 | -9.324 | -12.767 | -9.153 | -8.005 | -4.18 | -2.165 | -4.425 | -16.045 | -8.356 | -0.781 | -0.394 |
| Depreciation & Amortization
| 0 | 0.16 | 0.16 | 0.928 | 0 | 1.202 | 1.218 | 1.203 | 9.421 | 1.885 | 0.303 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0.217 | -0.02 | 0.116 | -0.335 | 0 | -0.079 | 0.372 | 0.166 | -1.017 | 2.079 | 0.254 | -0.181 |
| Accounts Receivables
| -0.016 | -0.099 | -0.034 | 0.045 | 0 | -0.017 | -0.044 | 0.04 | 0.062 | -0.221 | 0.119 | -0.044 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.137 |
| Other Working Capital
| 0.233 | 0 | 0.075 | -0.381 | 0 | -0.062 | 0.416 | 0.125 | -0.911 | 2.3 | 0.135 | -0.137 |
| Other Non Cash Items
| -5.133 | 0.24 | 2.557 | -0 | 2.046 | -0.676 | -2.024 | 0.02 | 0.243 | 0.033 | -0 | 0.041 |
| Operating Cash Flow
| -4.636 | -8.944 | -9.934 | -8.561 | -5.958 | -3.732 | -2.599 | -3.036 | -7.398 | -4.36 | -0.224 | -0.533 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | -0.006 | -0.001 | 0 | -1.775 |
| Acquisitions Net
| 0 | 0 | 0 | 0.004 | 0 | 0.007 | 0 | -0.061 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | -1.054 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.607 | -0.21 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0.012 | -0.843 | 0 |
| Investing Cash Flow
| 0.607 | -0.21 | -1.054 | 0.004 | 0 | 0.007 | -0 | -0.071 | -0.006 | -0.015 | -0.843 | -1.775 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -0.011 | -0.15 | -0.006 | -0.006 | 0.831 | 0.509 | 0.492 | 0.396 | 1.205 | 0.313 | 0.171 | 0.431 |
| Common Stock Issued
| 4.507 | 8.71 | 4.04 | 14.889 | 9.945 | 0 | 4.68 | 0 | 0.323 | 15.464 | 0.904 | 1.64 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0 | 0 | -0.006 | 0 | 0 | 0 | 0 | 0 | 0.904 | 0 |
| Financing Cash Flow
| 4.496 | 8.559 | 4.034 | 14.884 | 10.771 | 0.509 | 5.172 | 0.396 | 1.528 | 15.777 | 1.075 | 2.071 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0.467 | -1.404 | -6.084 | 6.327 | 4.812 | -3.216 | 2.573 | -2.711 | -5.876 | 11.416 | 0.009 | -0.237 |
| Cash At End Of Period
| 5.503 | 5.036 | 5.63 | 12.339 | 6.998 | 2.186 | 5.402 | 2.829 | 5.541 | 11.416 | 0.018 | 0.009 |